LITT Bibliography

MR-Guided Laser Ablation: LITT in Oncology, Imaging and Case Review

LITT Uses and Considerations for Gliomas, Metastases and Radiation Necrosis

Presenter: Peter E. Fecci, MD, PhD

Evidence for LITT and Blood-Brain Barrier Disruption

Breaking Barriers: The Evidence for Hyperthermia’s Therapeutic Disruption of the Blood Brain Barrier and the Outlook on Immune Benefits in the Brain

Presenter: Albert Kim, MD

Post-SRS progression, the importance of early intervention, and what the evidence tells us

See this important discussion on the challenges and opportunities for patients with radiographic progressive disease, including a look at the tools and evidence available to practitioners to address specific patient needs. This program also includes a review of the latest prospective outcomes documenting the efficacy of laser interstitial thermal therapy (LITT) for biopsy proven radiation necrosis, the value of early biopsy for these patients, and where LITT fits in the treatment spectrum.

Presenters: Roy Strowd III, MD; Michael Chan, MD; Adrian Laxton, MD

Evidence on LITT for pure IDH Wild-type glioblastoma cohort and more

Exciting new data on LITT for large cohort of pure IDH Wild–type glioblastoma, and a preview of promising studies on LITT and BBB disruption.

Presenter: John de Groot, MD

Laser Ablation and the Oncology Patient: New Evidence, What’s Coming and What You Need to Know

Discussion of LITT indications, uses and experiences in oncology.

Presenters: Peter E. Fecci, MD, PhD; John de Groot, MD; Roy Strowd III, MD

Stereotactic Laser Ablation in Neuro-oncology

Discussion of the rationale and principals of laser interstitial thermal therapy (LITT).

Presenter: Clark Chen, MD, PhD

Establishing an MR-Guided Laser Ablation Program

Discussion on the role of Laser Interstitial Thermal Therapy (LITT) in one group’s practice.

Presenters: Ian Lee, MD; James Snyder, DO

Updates on Laser Ablation in Neuro-Oncology – Efficacy of LITT for newly diagnosed and recurrent IDH wild-type glioblastoma

Discussion on LITT hospitalization, utilization and key outcomes of the recent prospective multi-center publication on the largest cohort to date of LITT for IDH wild-type glioblastoma. Clinical data updates for LITT in Mets and typical LITT case reviews.

Presenter: John de Groot, MD

Optimizing the Management of Recurrent Metastatic Brain Tumors: A Multi-Disciplinary Approach

Multi-disciplinary panelists share their experiences using LITT to manage recurrent metastatic brain tumors.

Presenters: Roy Strowd III, MD; Michael Chan, MD; Adrian Laxton, MD

CPT Codes for Intracranial LITT

Get the details on the Level 1 CPT codes for intracranial LITT.

Presenter: Lisa Hayden

Laser Ablation in Neuro Oncology

Discussion on laser ablation in neuro-oncology.

Presenters: John de Groot, MD; Roy Strowd III, MD

FEATURED LEARNING